| Cash Flow | 2025-10-24 | 2025-07-25 | 2025-01-24 | 2024-10-25 |
|---|---|---|---|---|
| Net income | 2,428 | 1,047 | 3,630 | 2,327 |
| Depreciation and amortization | 1,493 | 748 | 2,021 | 1,337 |
| Provision for credit losses | 66 | 28 | 96 | 45 |
| Deferred income taxes | 160 | 167 | -81 | 57 |
| Stock-based compensation | 268 | 86 | 340 | 242 |
| Other, net | -167 | -159 | -14 | 98 |
| Accounts receivable, net | -74 | -288 | 184 | 181 |
| Inventories | 672 | 373 | 478 | 278 |
| Accounts payable and accrued liabilities | -780 | -598 | -157 | -707 |
| Other operating assets and liabilities | 1,191 | 464 | 685 | 800 |
| Net cash provided by operating activities | 2,013 | 1,088 | 4,516 | 1,944 |
| Acquisitions, net of cash acquired | - | - | 98 | 0 |
| Additions to property, plant, and equipment | 972 | 504 | 1,400 | 924 |
| Purchases of investments | 4,201 | 2,100 | 6,093 | 4,019 |
| Sales and maturities of investments | 3,958 | 2,010 | 6,255 | 4,338 |
| Other investing activities, net | -14 | 125 | 111 | -1 |
| Net cash used in investing activities | -1,201 | -719 | -1,447 | -604 |
| Change in current debt obligations, net | 1,402 | 649 | -1,070 | -67 |
| Issuance of long-term debt | 1,747 | 0 | 3,209 | 3,209 |
| Payments on long-term debt | 2,930 | 1,162 | - | - |
| Dividends to shareholders | 1,820 | 910 | 2,692 | 1,795 |
| Issuance of ordinary shares | 255 | 95 | 400 | 232 |
| Repurchase of ordinary shares | 495 | 123 | 2,961 | 2,780 |
| Other financing activities, net | 65 | 70 | 96 | -64 |
| Net cash used in financing activities | -1,776 | -1,381 | -3,018 | -1,265 |
| Effect of exchange rate changes on cash and cash equivalents | 28 | 67 | -95 | 35 |
| Net change in cash and cash equivalents | -936 | -945 | -44 | 110 |
| Cash and cash equivalents at beginning of period | 2,218 | 2,218 | 1,284 | 1,284 |
| Cash and cash equivalents at end of period | 1,282 | 1,273 | 1,240 | 1,394 |
Medtronic plc (MDT)
Medtronic plc (MDT)